The Brand Name FIBRAL Has Generic Salt :: Fenofibrate 

FIBRAL  Is From Company Cardicare Priced :: Rs. 68

FIBRAL have Fenofibrate is comes under Sub class Anti Hyperlipidemics of  Main Class Cardiovascular System

Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti Hyperlipidemics 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Fenofibrate  CAP  Rs. 68  10
Brand Name Company / Manufacturers Strength Unit Price / 10
 FIBRAL  Cardicare  200MG  10 Rs. 68

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From Cardicare :: FIBRAL  Fenofibrate  Cardiovascular System Anti Hyperlipidemics

Indications for Drugs ::

Hyperlipidemia,Hypercholesterolaemia,Hypertriglyceridaemia

Drug Dose ::

Adult: PO : Standard micronised formulation: Initially, 200 mg once daily. For non-micronised formulations: Initial: 200-300 mg/day in divided doses. Usual range: 200-400 mg/day. Formulation w/ improved bioavailability: 40-160 mg once daily may be used.

Contraindication ::

Hypersensitivity; severe hepatic and renal impairment. Unexplained persistent liver function abnormality and primary biliary cirrhosis; preexisting gall bladder disease. Pregnancy, lactation.

Drug Precautions ::

Renal or hepatic impairment. Monitor LFTs and blood counts regularly. Increased risk of cholelithiasis, pancreatitis, skeletal muscle effects. Withdraw treatment if no adequate response after 2 mth of treatment at max recommended dose.

Drug Side Effects ::

Headache, dizziness, asthaenia, fatigue, arrhythmia, photosensitivity, eczema, dizziness, vaginitis, paraesthesia, rhinitis, cough, sinusitis, allergic pulmonary alveolitis, polyuria, myopathy, myositis, arthralgia, myalgia, myasthenia. Potentially Fatal: Hepatitis, cholecystitis.

Pregnancy category ::
Pregnancy category

3

Drug Mode of Action ::  

Fenofibrate, a fibric acid derivative, lowers plasma triglyceride by activating lipoprotein lipase thus increasing catabolism of VLDL w/ consequent increase in HDL levels.

Drug Interactions ::

Decreased absorption w/ bile acid sequestrants (e.g. colestyramine). May increase risk of ciclosporin-induced nephrotoxicity. Increased risk of muscle toxicity w/ HMG-CoA reductase inhibitors (e.g. simvastatin). May increase risk of bleeding w/ oral anticoagulants.

 

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.